Global Point of Care
Panbio™ COVID-19 IgG Rapid Test Device 可檢測針對 SARS-CoV-2剌突蛋白受體結合區 (S1-RBD) 的免疫球蛋白 G (IgG) 抗體。本測試可識別先前感染過 COVID-19 或疫苗接種後抗體的個體。
本抗體測試可幫助您：
本產品僅在部分國家銷售。.
| 症狀發作後 21 - 180 天 |
|---|
| 96.7% 靈敏度 (PPA) |
| 97.0% 特異性 (NPA) |
| 第二劑疫苗接種後 ≥ 30 天** |
| 98.4% 靈敏度 (PPA) |
| 97.0% 特異性 (NPA) |
*前瞻性指尖穿刺檢體研究
**將接種疫苗的受試者在第二劑 BNT162b2 疫苗 (Pfizer-BioNTech) 或 mRNA-1273 疫苗 (Moderna) 後 30 天或更長時間後加入研究。
S簡單的指尖採血測試程序，可直觀地進行結果判讀。
| Panbio™ COVID-19 IgG Rapid Test Device | 代碼 |
|---|---|
| Panbio™ COVID-19 IgG Rapid Test Device（25 套分析組件） | ICO-40206 |
| Panbio™ COVID-19 IgG Control Kit | CPK-033 |
A Leader In Rapid Point-of-care Diagnostics.
©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
